EGFR and cancer: What is more, many sub-pathways of “Pathways in cancer” were enriched, such as “MAPK signaling pathway”, “PI3K-Akt signaling pathway”, “FoxO signaling pathway”, “Proteoglycans in cancer”, “Jak-STAT signaling pathway”, “Regulation of actin cytoskeleton”, “Focal adhesion” and “ErbB signaling pathway”.